Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Alfred

Showing results (61-70 of 434) with videos related to

Pageof 44
Sort By:
European Urology|June 14, 2011
Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic reviewSven van den Bosch, J Alfred Witjes
Expert Review of Anticancer Therapy|June 29, 2011
Discussion on the influence of HER2 status on the clinical outcome of bladder cancer continuesRianne J M Lammers, J Alfred Witjes
The Physician and Sportsmedicine|December 22, 2017
Flexibility as a Predictor of Knee Injuries in College Football PlayersJ Alfred Moretz, Rod Walters, Lloyd Smith
Expert Review of Anticancer Therapy|November 30, 2010
Developments in intravesical therapy for non-muscle-invasive bladder cancerRianne J M Lammers, J Alfred Witjes
Metabolism: Clinical and Experimental|March 27, 1999
The blood vessel, linchpin of diabetic lesionsG E Plante, J Alfred, M Chakir
European Urology|July 19, 2016
Reply to Sławomir Poletajew, Piotr Radziszewski, Juan Palou's Letter to the Editor re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046-52Tom J H Arends, J Alfred Witjes
European Urology|December 29, 2007
Urinary markers in bladder cancerOlaf P J Vrooman, J Alfred Witjes
Expert Opinion on Biological Therapy|August 21, 2013
Current intravesical therapy for non-muscle invasive bladder cancerAnna V van Lingen, J Alfred Witjes
Current Opinion in Urology|July 27, 2010
Follow-up of patients after curative bladder cancer treatment: guidelines vs. practiceOlaf P J Vrooman, J Alfred Witjes
International Journal of Urology : Official Journal of the Japanese Urological Association|March 21, 2009
Molecular markers for detection, surveillance and prognostication of bladder cancerOlaf P J Vrooman, J Alfred Witjes
Pageof 44

Showing results (61-70 of 434) with videos related to

Sort By:
Pageof 44
European Urology|June 14, 2011
Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic reviewSven van den Bosch, J Alfred Witjes
Expert Review of Anticancer Therapy|June 29, 2011
Discussion on the influence of HER2 status on the clinical outcome of bladder cancer continuesRianne J M Lammers, J Alfred Witjes
The Physician and Sportsmedicine|December 22, 2017
Flexibility as a Predictor of Knee Injuries in College Football PlayersJ Alfred Moretz, Rod Walters, Lloyd Smith
Expert Review of Anticancer Therapy|November 30, 2010
Developments in intravesical therapy for non-muscle-invasive bladder cancerRianne J M Lammers, J Alfred Witjes
Metabolism: Clinical and Experimental|March 27, 1999
The blood vessel, linchpin of diabetic lesionsG E Plante, J Alfred, M Chakir
European Urology|July 19, 2016
Reply to Sławomir Poletajew, Piotr Radziszewski, Juan Palou's Letter to the Editor re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046-52Tom J H Arends, J Alfred Witjes
European Urology|December 29, 2007
Urinary markers in bladder cancerOlaf P J Vrooman, J Alfred Witjes
Expert Opinion on Biological Therapy|August 21, 2013
Current intravesical therapy for non-muscle invasive bladder cancerAnna V van Lingen, J Alfred Witjes
Current Opinion in Urology|July 27, 2010
Follow-up of patients after curative bladder cancer treatment: guidelines vs. practiceOlaf P J Vrooman, J Alfred Witjes
International Journal of Urology : Official Journal of the Japanese Urological Association|March 21, 2009
Molecular markers for detection, surveillance and prognostication of bladder cancerOlaf P J Vrooman, J Alfred Witjes
Pageof 44